Indonesia approves emergency use of China's mRNA COVID-19 vaccine

**This is a 60-seconds sample of the video. For the full version, please contact us.**

Indonesia approves emergency use of China's mRNA COVID-19 vaccine

STORY: Indonesia approves emergency use of China's mRNA COVID-19 vaccine DATELINE: Oct. 1, 2022 LENGTH: 0:01:17 LOCATION: Jakarta CATEGORY: HEALTH/MEDICINE SHOTLIST: 1. STANDUP (English): SUN LEI, Xinhua correspondent 2. various of press release 3. SOUNDBITE 1 (English): PENNY LUKITO, Head of Indonesia's Food and Drug Monitoring Agency (BPOM) 4. SOUNDBITE 2 (English): ANDREAS DONNY, PT Etana Biotechnologies Indonesia 5. various of mRNA vaccine 6. various of BPOM STORYLINE: The Indonesian food and drug administration (BPOM) has issued an emergency use authorization (EUA) for the mRNA-platform COVID-19 vaccine, AWcorna, developed by Chinese companies. STANDUP (English): SUN LEI, Xinhua correspondent "The Indonesian food and drug authority BPOM has authorized a China-made mRNA vaccine for emergency use in individuals 18 years of age or above, as either primary or booster dose." AWcorna is a SARS-CoV-2 mRNA vaccine developed by Suzhou Abogen Biosciences Co., Ltd. with the participation of Walvax Biotechnolog

  • Product Code
  • ILEA001022455
  • Registered date
  • 2022/10/01 00:00:00
  • Credit
  • Xinhua / Kyodo News Images
  • Media source
  • Xinhua News Agency.All Rights Reserved
  • Media size
  • 1920 × 1080 pixel
  • Deployment size
  • 82.05(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos